Purpose: The relationship between plasma lipid levels and neoplastic diseases is still unclear The aim of this study was to analyse the lipid profile of individuals with non-Hodgkin lymphoma (NHL) or prostate carcinoma (CaP) and to follow serum lipid levels changes in NHL patients according to their response to chemotherapy. Patients and methods: Forty-seven patients with NHL, 57 patients with CaP two control groups composed of 29 and 43 age- and sex-matched healthy adults, related to NHL and CaP patients, respectively, were included in the study. Follow-up studies of NHL patients were carried out after the 3rd and 6th cycle of chemotherapy. Results: Initial plasma cholesterol (Chol), HDL-cholesterol (HDL-Chol) and phospholipids (PL) values were signficantly lower in patients with NHL or CaP than in controls. Following chemotherapy we noticed a progressive increase in lipid levels in NHL patients with complete remission (CR) and stable disease (SD), and further decrease in patients wit...h the disease progression. Conclusion: Decreased plasma Chol, HDL-Chol and PL levels of patients with NHL or CaP can be considered as nonspecific prognostic parameters in patients with these malignancies.
TY - JOUR
AU - Cvetković, Z.
AU - Cvetković, B.
AU - Petrović, M.
AU - Ranić, Marija M.
AU - Debeljak-Martačić, Jasmina D.
AU - Vučić, Vesna M.
AU - Glibetić, Marija
PY - 2009
UR - http://rimi.imi.bg.ac.rs/handle/123456789/222
AB - Purpose: The relationship between plasma lipid levels and neoplastic diseases is still unclear The aim of this study was to analyse the lipid profile of individuals with non-Hodgkin lymphoma (NHL) or prostate carcinoma (CaP) and to follow serum lipid levels changes in NHL patients according to their response to chemotherapy. Patients and methods: Forty-seven patients with NHL, 57 patients with CaP two control groups composed of 29 and 43 age- and sex-matched healthy adults, related to NHL and CaP patients, respectively, were included in the study. Follow-up studies of NHL patients were carried out after the 3rd and 6th cycle of chemotherapy. Results: Initial plasma cholesterol (Chol), HDL-cholesterol (HDL-Chol) and phospholipids (PL) values were signficantly lower in patients with NHL or CaP than in controls. Following chemotherapy we noticed a progressive increase in lipid levels in NHL patients with complete remission (CR) and stable disease (SD), and further decrease in patients with the disease progression. Conclusion: Decreased plasma Chol, HDL-Chol and PL levels of patients with NHL or CaP can be considered as nonspecific prognostic parameters in patients with these malignancies.
PB - Balkan Union of Oncology (B.U.ON.)
T2 - Journal of BUON
T1 - Lipid profile as a prognostic factor in cancer patients
EP - 506
IS - 3
SP - 501
VL - 14
UR - https://hdl.handle.net/21.15107/rcub_rimi_222
ER -
@article{
author = "Cvetković, Z. and Cvetković, B. and Petrović, M. and Ranić, Marija M. and Debeljak-Martačić, Jasmina D. and Vučić, Vesna M. and Glibetić, Marija",
year = "2009",
abstract = "Purpose: The relationship between plasma lipid levels and neoplastic diseases is still unclear The aim of this study was to analyse the lipid profile of individuals with non-Hodgkin lymphoma (NHL) or prostate carcinoma (CaP) and to follow serum lipid levels changes in NHL patients according to their response to chemotherapy. Patients and methods: Forty-seven patients with NHL, 57 patients with CaP two control groups composed of 29 and 43 age- and sex-matched healthy adults, related to NHL and CaP patients, respectively, were included in the study. Follow-up studies of NHL patients were carried out after the 3rd and 6th cycle of chemotherapy. Results: Initial plasma cholesterol (Chol), HDL-cholesterol (HDL-Chol) and phospholipids (PL) values were signficantly lower in patients with NHL or CaP than in controls. Following chemotherapy we noticed a progressive increase in lipid levels in NHL patients with complete remission (CR) and stable disease (SD), and further decrease in patients with the disease progression. Conclusion: Decreased plasma Chol, HDL-Chol and PL levels of patients with NHL or CaP can be considered as nonspecific prognostic parameters in patients with these malignancies.",
publisher = "Balkan Union of Oncology (B.U.ON.)",
journal = "Journal of BUON",
title = "Lipid profile as a prognostic factor in cancer patients",
pages = "506-501",
number = "3",
volume = "14",
url = "https://hdl.handle.net/21.15107/rcub_rimi_222"
}
Cvetković, Z., Cvetković, B., Petrović, M., Ranić, M. M., Debeljak-Martačić, J. D., Vučić, V. M.,& Glibetić, M.. (2009). Lipid profile as a prognostic factor in cancer patients. in Journal of BUON
Balkan Union of Oncology (B.U.ON.)., 14(3), 501-506.
https://hdl.handle.net/21.15107/rcub_rimi_222
Cvetković Z, Cvetković B, Petrović M, Ranić MM, Debeljak-Martačić JD, Vučić VM, Glibetić M. Lipid profile as a prognostic factor in cancer patients. in Journal of BUON. 2009;14(3):501-506.
https://hdl.handle.net/21.15107/rcub_rimi_222 .
Cvetković, Z., Cvetković, B., Petrović, M., Ranić, Marija M., Debeljak-Martačić, Jasmina D., Vučić, Vesna M., Glibetić, Marija, "Lipid profile as a prognostic factor in cancer patients" in Journal of BUON, 14, no. 3 (2009):501-506,
https://hdl.handle.net/21.15107/rcub_rimi_222 .
